163 related articles for article (PubMed ID: 22378101)
1. Interferon-induced thyroiditis during treatment of chronic hepatitis C.
Kozielewicz D; Halota W
Endokrynol Pol; 2012; 63(1):66-70. PubMed ID: 22378101
[TBL] [Abstract][Full Text] [Related]
2. Interferon induced thyroiditis.
Tomer Y; Menconi F
Best Pract Res Clin Endocrinol Metab; 2009 Dec; 23(6):703-12. PubMed ID: 19942147
[TBL] [Abstract][Full Text] [Related]
3. Incidence of and risk factors for thyroid dysfunction during peginterferon α and ribavirin treatment in patients with chronic hepatitis C.
Hwang Y; Kim W; Kwon SY; Yu HM; Kim JH; Choe WH
Korean J Intern Med; 2015 Nov; 30(6):792-800. PubMed ID: 26552454
[TBL] [Abstract][Full Text] [Related]
4. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
[TBL] [Abstract][Full Text] [Related]
5. Interferon alpha-induced hashimoto thyroiditis followed by transient graves disease in a patient with chronic HCV infection.
Savvas SP; Papakostas N; Giannaris M; Malaktari S; Koskinas J; Archimandritis AJ
South Med J; 2010 Jun; 103(6):585-8. PubMed ID: 20710148
[TBL] [Abstract][Full Text] [Related]
6. Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin--a review.
Andrade LJ; Atta AM; D'Almeida Junior A; Paraná R
Braz J Infect Dis; 2008 Apr; 12(2):144-8. PubMed ID: 18641852
[TBL] [Abstract][Full Text] [Related]
7. Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin.
Danilovic DL; Mendes-Correa MC; Chammas MC; Zambrini H; Marui S
Clinics (Sao Paulo); 2011; 66(10):1757-63. PubMed ID: 22012048
[TBL] [Abstract][Full Text] [Related]
8. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification.
Mandac JC; Chaudhry S; Sherman KE; Tomer Y
Hepatology; 2006 Apr; 43(4):661-72. PubMed ID: 16557537
[TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha-induced destructive thyroiditis followed by Graves' disease in a patient with chronic hepatitis C: a case report.
Kim BK; Choi YS; Park YH; Lee SU
J Korean Med Sci; 2011 Dec; 26(12):1638-41. PubMed ID: 22148004
[TBL] [Abstract][Full Text] [Related]
10. The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism.
Carella C; Mazziotti G; Morisco F; Rotondi M; Cioffi M; Tuccillo C; Sorvillo F; Caporaso N; Amato G
Eur J Endocrinol; 2002 Jun; 146(6):743-9. PubMed ID: 12039693
[TBL] [Abstract][Full Text] [Related]
11. Thyroid dysfunction during interferon alpha therapy for chronic hepatitis C.
Shen L; Bui C; Mansberg R; Nguyen D; Alam-Fotias S
Clin Nucl Med; 2005 Aug; 30(8):546-7. PubMed ID: 16024950
[TBL] [Abstract][Full Text] [Related]
12. [Side effects during interferon-alpha therapy of hepatitis C with special consideration of thyroid dysfunction].
Obołończyk L; Obołończyk L; Siekierska-Hellmann M; Sworczak K
Postepy Hig Med Dosw (Online); 2007 Jun; 62():309-21. PubMed ID: 18583950
[TBL] [Abstract][Full Text] [Related]
13. Hashimoto's thyroiditis following Graves' disease.
Umar H; Muallima N; Adam JM; Sanusi H
Acta Med Indones; 2010 Jan; 42(1):31-5. PubMed ID: 20305330
[TBL] [Abstract][Full Text] [Related]
14. [Thyrotoxicosis induced by interferonotherapy of chronic hepatitis C in a woman with Hashimoto's thyroiditis].
Kozielewicz D; Junik R; Halota W
Pol Merkur Lekarski; 2014 Aug; 37(218):108-10. PubMed ID: 25252446
[TBL] [Abstract][Full Text] [Related]
15. Phenotypes of interferon-α-induced thyroid dysfunction among patients treated for hepatitis C are associated with pretreatment serum TSH and female sex.
Mammen JS; Ghazarian SR; Pulkstenis E; Subramanian GM; Rosen A; Ladenson PW
J Clin Endocrinol Metab; 2012 Sep; 97(9):3270-6. PubMed ID: 22689690
[TBL] [Abstract][Full Text] [Related]
16. Thyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspective.
Tran HA; Jones TL; Ianna EA; Foy A; Reeves GE
Endocr Pract; 2013; 19(2):292-300. PubMed ID: 23186968
[TBL] [Abstract][Full Text] [Related]
17. The influence of interferon alpha on the induction of autoimmune thyroiditis in patients treated for chronic viral hepatitis type C.
Krupińska J; Wawrzynowicz-Syczewska M; Urbanowicz W; Pobłocki J; Syrenicz A
Endokrynol Pol; 2011; 62(6):517-22. PubMed ID: 22144218
[TBL] [Abstract][Full Text] [Related]
18. [Clinical observation of Hashimoto thyroiditis in patients with chronic hepatitis C undergoing pegylated-interferon alpha-2a and ribavirin combination therapy].
Teng ZL; Gong WJ; Zhang SQ; Sun YX; Ma XH
Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):101-4. PubMed ID: 23663880
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology, risk factors and prognosis of Interferon alpha induced thyroid disorders. A Prospective Clinical Study.
Obołończyk Ł; Siekierska-Hellmann M; Wiśniewski P; Lewczuk A; Berendt-Obołończyk M; Lakomy A; Michalska Z; Radowska D; Moszkowska G; Bianek-Bodzak A; Sworczak K
Postepy Hig Med Dosw (Online); 2017 Sep; 71(0):842-849. PubMed ID: 29039351
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of thyroid dysfunction and influencing factors in chronic hepatitis C patients treated with peg-IFNa-2a and ribavirin].
Huang YX; Chen XY; Ma LN; Yin JM; Ren S; Guo DD; Zheng YH
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):216-20. PubMed ID: 22475143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
